rs34605986

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000478.6(ALPL):​c.1565T>C​(p.Val522Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,597,356 control chromosomes in the GnomAD database, including 9,914 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V522I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.080 ( 594 hom., cov: 33)
Exomes 𝑓: 0.11 ( 9320 hom. )

Consequence

ALPL
NM_000478.6 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15O:1

Conservation

PhyloP100: -0.497
Variant links:
Genes affected
ALPL (HGNC:438): (alkaline phosphatase, biomineralization associated) This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013977885).
BP6
Variant 1-21577638-T-C is Benign according to our data. Variant chr1-21577638-T-C is described in ClinVar as [Benign]. Clinvar id is 193996.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-21577638-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.143 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALPLNM_000478.6 linkc.1565T>C p.Val522Ala missense_variant Exon 12 of 12 ENST00000374840.8 NP_000469.3 P05186-1A0A024RAB4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALPLENST00000374840.8 linkc.1565T>C p.Val522Ala missense_variant Exon 12 of 12 1 NM_000478.6 ENSP00000363973.3 P05186-1

Frequencies

GnomAD3 genomes
AF:
0.0805
AC:
12243
AN:
152130
Hom.:
590
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0366
Gnomad AMI
AF:
0.146
Gnomad AMR
AF:
0.0759
Gnomad ASJ
AF:
0.100
Gnomad EAS
AF:
0.00328
Gnomad SAS
AF:
0.152
Gnomad FIN
AF:
0.0602
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.110
Gnomad OTH
AF:
0.0817
GnomAD3 exomes
AF:
0.0961
AC:
21977
AN:
228758
Hom.:
1252
AF XY:
0.102
AC XY:
12871
AN XY:
126330
show subpopulations
Gnomad AFR exome
AF:
0.0339
Gnomad AMR exome
AF:
0.0736
Gnomad ASJ exome
AF:
0.102
Gnomad EAS exome
AF:
0.00223
Gnomad SAS exome
AF:
0.167
Gnomad FIN exome
AF:
0.0559
Gnomad NFE exome
AF:
0.111
Gnomad OTH exome
AF:
0.0944
GnomAD4 exome
AF:
0.109
AC:
158043
AN:
1445108
Hom.:
9320
Cov.:
35
AF XY:
0.111
AC XY:
79829
AN XY:
719296
show subpopulations
Gnomad4 AFR exome
AF:
0.0333
Gnomad4 AMR exome
AF:
0.0735
Gnomad4 ASJ exome
AF:
0.0957
Gnomad4 EAS exome
AF:
0.00162
Gnomad4 SAS exome
AF:
0.164
Gnomad4 FIN exome
AF:
0.0599
Gnomad4 NFE exome
AF:
0.115
Gnomad4 OTH exome
AF:
0.102
GnomAD4 genome
AF:
0.0804
AC:
12247
AN:
152248
Hom.:
594
Cov.:
33
AF XY:
0.0784
AC XY:
5834
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.0365
Gnomad4 AMR
AF:
0.0757
Gnomad4 ASJ
AF:
0.100
Gnomad4 EAS
AF:
0.00329
Gnomad4 SAS
AF:
0.152
Gnomad4 FIN
AF:
0.0602
Gnomad4 NFE
AF:
0.110
Gnomad4 OTH
AF:
0.0833
Alfa
AF:
0.0967
Hom.:
246
Bravo
AF:
0.0781
TwinsUK
AF:
0.114
AC:
423
ALSPAC
AF:
0.112
AC:
432
ESP6500AA
AF:
0.0357
AC:
155
ESP6500EA
AF:
0.0967
AC:
822
ExAC
AF:
0.0936
AC:
11262
Asia WGS
AF:
0.0830
AC:
293
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:15Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Oct 24, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 26, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 30, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hypophosphatasia Benign:3Other:1
-
GeneReviews
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dec 10, 2024
JKU Lab, Dept of Paediatrics, Johannes Kepler University
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: curation;in vitro

This missense variant is present in GnomAD 4.1 (ƒ = 0.109) and affects a weakly conserved amino acid. The variant is predicted to affect protein function (REVEL score: 0.257). Splice-prediction algorithms predict no effect on splicing. In vitro functional studies showed normal ALP activity. This variant has been reported in the literature in individuals affected with ALPL-related conditions (PMID: 30680361). The results of the functional testing and the applied ACMG criteria can be viewed at: https://alplmutationdatabase.jku.at/table/ -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Infantile hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Adult hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Childhood hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
7.8
DANN
Benign
0.65
DEOGEN2
Benign
0.19
T;.;.;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.075
N
LIST_S2
Benign
0.31
.;T;T;T
MetaRNN
Benign
0.0014
T;T;T;T
MetaSVM
Benign
-0.57
T
MutationAssessor
Benign
0.0
N;.;.;N
PrimateAI
Benign
0.38
T
PROVEAN
Benign
0.050
N;N;N;N
REVEL
Benign
0.26
Sift
Benign
0.051
T;T;T;T
Sift4G
Uncertain
0.046
D;D;D;D
Polyphen
0.0030
B;.;.;B
Vest4
0.057
MPC
0.49
ClinPred
0.0029
T
GERP RS
-5.6
Varity_R
0.038
gMVP
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34605986; hg19: chr1-21904131; COSMIC: COSV66375923; API